 | • レポートコード：GIR201114235 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、医薬品安全性ソリューション・ファーマコビジランスの世界市場を調査対象にし、医薬品安全性ソリューション・ファーマコビジランスの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（標準フォーム、カスタマイズフォーム）、用途別分析（バイオテクノロジー・医薬品、受託研究機関（CROS）、病院、KPO/BPO、医療機関、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Pharmaceutical Product Development, LLC、AB Cube、Worldwide Clinical Trials、Drug Safety Solutions Limited、Ennov、C3i、Accenture、United Biosource LLC、Bioclinica、Covance Inc.、Cognizant、ICON plc、PRA Health Sciences, Inc.、Syneos Health、Parexel International Corporation、Genpact、Ergomed、Oracle、ArisGlobal、IQVIA ・企業別売上、市場シェア ・医薬品安全性ソリューション・ファーマコビジランスの地域別市場分析 ・医薬品安全性ソリューション・ファーマコビジランスの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・医薬品安全性ソリューション・ファーマコビジランスのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・医薬品安全性ソリューション・ファーマコビジランスのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・医薬品安全性ソリューション・ファーマコビジランスの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・医薬品安全性ソリューション・ファーマコビジランスの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・医薬品安全性ソリューション・ファーマコビジランスの種類別市場規模2015-2020：標準フォーム、カスタマイズフォーム ・医薬品安全性ソリューション・ファーマコビジランスの用途別市場規模2015-2020：バイオテクノロジー・医薬品、受託研究機関（CROS）、病院、KPO/BPO、医療機関、その他 ・医薬品安全性ソリューション・ファーマコビジランスの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Drug Safety Solutions and Pharmacovigilance market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Drug Safety Solutions and Pharmacovigilance market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Drug Safety Solutions and Pharmacovigilance market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Drug Safety Solutions and Pharmacovigilance market has been segmented into:
Standard Form
Customized Form
By Application, Drug Safety Solutions and Pharmacovigilance has been segmented into:
Biotechnology and Pharmaceuticals
Contract Research Organization (CROS)
Hospital
KPO / BPO
Healthcare Institutions
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Drug Safety Solutions and Pharmacovigilance market presented in the report. This section sheds light on the sales growth of different regional and country-level Drug Safety Solutions and Pharmacovigilance markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Drug Safety Solutions and Pharmacovigilance market.
The report offers in-depth assessment of the growth and other aspects of the Drug Safety Solutions and Pharmacovigilance market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Drug Safety Solutions and Pharmacovigilance Market Share Analysis
Drug Safety Solutions and Pharmacovigilance competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Drug Safety Solutions and Pharmacovigilance sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Drug Safety Solutions and Pharmacovigilance sales, revenue and market share for each player covered in this report.
The major players covered in Drug Safety Solutions and Pharmacovigilance are:
Pharmaceutical Product Development, LLC
AB Cube
Worldwide Clinical Trials
Drug Safety Solutions Limited
Ennov
C3i
Accenture
United Biosource LLC
Bioclinica
Covance Inc.
Cognizant
ICON plc
PRA Health Sciences, Inc.
Syneos Health
Parexel International Corporation
Genpact
Ergomed
Oracle
ArisGlobal
IQVIA
Table of Contents
1 Drug Safety Solutions and Pharmacovigilance Market Overview
1.1 Product Overview and Scope of Drug Safety Solutions and Pharmacovigilance
1.2 Classification of Drug Safety Solutions and Pharmacovigilance by Type
1.2.1 Global Drug Safety Solutions and Pharmacovigilance Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Type in 2019
1.2.3 Standard Form
1.2.4 Customized Form
1.3 Global Drug Safety Solutions and Pharmacovigilance Market by Application
1.3.1 Overview: Global Drug Safety Solutions and Pharmacovigilance Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Biotechnology and Pharmaceuticals
1.3.3 Contract Research Organization (CROS)
1.3.4 Hospital
1.3.5 KPO / BPO
1.3.6 Healthcare Institutions
1.3.7 Others
1.4 Global Drug Safety Solutions and Pharmacovigilance Market by Regions
1.4.1 Global Drug Safety Solutions and Pharmacovigilance Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Drug Safety Solutions and Pharmacovigilance (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Drug Safety Solutions and Pharmacovigilance Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Drug Safety Solutions and Pharmacovigilance Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Drug Safety Solutions and Pharmacovigilance Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Drug Safety Solutions and Pharmacovigilance Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Drug Safety Solutions and Pharmacovigilance Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pharmaceutical Product Development, LLC
2.1.1 Pharmaceutical Product Development, LLC Details
2.1.2 Pharmaceutical Product Development, LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pharmaceutical Product Development, LLC SWOT Analysis
2.1.4 Pharmaceutical Product Development, LLC Product and Services
2.1.5 Pharmaceutical Product Development, LLC Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2018-2019)
2.2 AB Cube
2.2.1 AB Cube Details
2.2.2 AB Cube Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 AB Cube SWOT Analysis
2.2.4 AB Cube Product and Services
2.2.5 AB Cube Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2018-2019)
2.3 Worldwide Clinical Trials
2.3.1 Worldwide Clinical Trials Details
2.3.2 Worldwide Clinical Trials Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Worldwide Clinical Trials SWOT Analysis
2.3.4 Worldwide Clinical Trials Product and Services
2.3.5 Worldwide Clinical Trials Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2018-2019)
2.4 Drug Safety Solutions Limited
2.4.1 Drug Safety Solutions Limited Details
2.4.2 Drug Safety Solutions Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Drug Safety Solutions Limited SWOT Analysis
2.4.4 Drug Safety Solutions Limited Product and Services
2.4.5 Drug Safety Solutions Limited Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ennov
2.5.1 Ennov Details
2.5.2 Ennov Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Ennov SWOT Analysis
2.5.4 Ennov Product and Services
2.5.5 Ennov Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2018-2019)
2.6 C3i
2.6.1 C3i Details
2.6.2 C3i Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 C3i SWOT Analysis
2.6.4 C3i Product and Services
2.6.5 C3i Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2018-2019)
2.7 Accenture
2.7.1 Accenture Details
2.7.2 Accenture Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Accenture SWOT Analysis
2.7.4 Accenture Product and Services
2.7.5 Accenture Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2018-2019)
2.8 United Biosource LLC
2.8.1 United Biosource LLC Details
2.8.2 United Biosource LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 United Biosource LLC SWOT Analysis
2.8.4 United Biosource LLC Product and Services
2.8.5 United Biosource LLC Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bioclinica
2.9.1 Bioclinica Details
2.9.2 Bioclinica Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bioclinica SWOT Analysis
2.9.4 Bioclinica Product and Services
2.9.5 Bioclinica Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2018-2019)
2.10 Covance Inc.
2.10.1 Covance Inc. Details
2.10.2 Covance Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Covance Inc. SWOT Analysis
2.10.4 Covance Inc. Product and Services
2.10.5 Covance Inc. Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2018-2019)
2.11 Cognizant
2.11.1 Cognizant Details
2.11.2 Cognizant Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Cognizant SWOT Analysis
2.11.4 Cognizant Product and Services
2.11.5 Cognizant Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2018-2019)
2.12 ICON plc
2.12.1 ICON plc Details
2.12.2 ICON plc Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 ICON plc SWOT Analysis
2.12.4 ICON plc Product and Services
2.12.5 ICON plc Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2018-2019)
2.13 PRA Health Sciences, Inc.
2.13.1 PRA Health Sciences, Inc. Details
2.13.2 PRA Health Sciences, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 PRA Health Sciences, Inc. SWOT Analysis
2.13.4 PRA Health Sciences, Inc. Product and Services
2.13.5 PRA Health Sciences, Inc. Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2018-2019)
2.14 Syneos Health
2.14.1 Syneos Health Details
2.14.2 Syneos Health Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Syneos Health SWOT Analysis
2.14.4 Syneos Health Product and Services
2.14.5 Syneos Health Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2018-2019)
2.15 Parexel International Corporation
2.15.1 Parexel International Corporation Details
2.15.2 Parexel International Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Parexel International Corporation SWOT Analysis
2.15.4 Parexel International Corporation Product and Services
2.15.5 Parexel International Corporation Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2018-2019)
2.16 Genpact
2.16.1 Genpact Details
2.16.2 Genpact Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Genpact SWOT Analysis
2.16.4 Genpact Product and Services
2.16.5 Genpact Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2018-2019)
2.17 Ergomed
2.17.1 Ergomed Details
2.17.2 Ergomed Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Ergomed SWOT Analysis
2.17.4 Ergomed Product and Services
2.17.5 Ergomed Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2018-2019)
2.18 Oracle
2.18.1 Oracle Details
2.18.2 Oracle Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Oracle SWOT Analysis
2.18.4 Oracle Product and Services
2.18.3 Oracle Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2018-2019)
2.19 ArisGlobal
2.19.1 ArisGlobal Details
2.19.2 ArisGlobal Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 ArisGlobal SWOT Analysis
2.19.4 ArisGlobal Product and Services
2.19.5 ArisGlobal Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2018-2019)
2.20 IQVIA
2.20.1 IQVIA Details
2.20.2 IQVIA Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 IQVIA SWOT Analysis
2.20.4 IQVIA Product and Services
2.20.5 IQVIA Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Drug Safety Solutions and Pharmacovigilance Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Drug Safety Solutions and Pharmacovigilance Players Market Share
3.2.2 Top 10 Drug Safety Solutions and Pharmacovigilance Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Drug Safety Solutions and Pharmacovigilance Revenue and Market Share by Regions
4.2 North America Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
4.3 Europe Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
4.5 South America Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
5 North America Drug Safety Solutions and Pharmacovigilance Revenue by Countries
5.1 North America Drug Safety Solutions and Pharmacovigilance Revenue by Countries (2015-2020)
5.2 USA Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
5.3 Canada Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
5.4 Mexico Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
6 Europe Drug Safety Solutions and Pharmacovigilance Revenue by Countries
6.1 Europe Drug Safety Solutions and Pharmacovigilance Revenue by Countries (2015-2020)
6.2 Germany Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
6.3 UK Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
6.4 France Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
6.5 Russia Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
6.6 Italy Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue by Countries
7.1 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue by Countries (2015-2020)
7.2 China Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
7.3 Japan Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
7.4 Korea Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
7.5 India Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
8 South America Drug Safety Solutions and Pharmacovigilance Revenue by Countries
8.1 South America Drug Safety Solutions and Pharmacovigilance Revenue by Countries (2015-2020)
8.2 Brazil Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
8.3 Argentina Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Drug Safety Solutions and Pharmacovigilance by Countries
9.1 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Revenue by Countries (2015-2020)
9.2 Saudi Arabia Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
9.3 UAE Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
9.4 Egypt Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
9.5 South Africa Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Drug Safety Solutions and Pharmacovigilance Revenue and Market Share by Type (2015-2020)
10.2 Global Drug Safety Solutions and Pharmacovigilance Market Forecast by Type (2019-2024)
10.3 Standard Form Revenue Growth Rate (2015-2025)
10.4 Customized Form Revenue Growth Rate (2015-2025)
11 Global Drug Safety Solutions and Pharmacovigilance Market Segment by Application
11.1 Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Application (2015-2020)
11.2 Drug Safety Solutions and Pharmacovigilance Market Forecast by Application (2019-2024)
11.3 Biotechnology and Pharmaceuticals Revenue Growth (2015-2020)
11.4 Contract Research Organization (CROS) Revenue Growth (2015-2020)
11.5 Hospital Revenue Growth (2015-2020)
11.6 KPO / BPO Revenue Growth (2015-2020)
11.7 Healthcare Institutions Revenue Growth (2015-2020)
11.8 Others Revenue Growth (2015-2020)
12 Global Drug Safety Solutions and Pharmacovigilance Market Size Forecast (2021-2025)
12.1 Global Drug Safety Solutions and Pharmacovigilance Market Size Forecast (2021-2025)
12.2 Global Drug Safety Solutions and Pharmacovigilance Market Forecast by Regions (2021-2025)
12.3 North America Drug Safety Solutions and Pharmacovigilance Revenue Market Forecast (2021-2025)
12.4 Europe Drug Safety Solutions and Pharmacovigilance Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue Market Forecast (2021-2025)
12.6 South America Drug Safety Solutions and Pharmacovigilance Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Drug Safety Solutions and Pharmacovigilance Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Drug Safety Solutions and Pharmacovigilance by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Drug Safety Solutions and Pharmacovigilance Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Drug Safety Solutions and Pharmacovigilance Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pharmaceutical Product Development, LLC Corporate Information, Location and Competitors
Table 6. Pharmaceutical Product Development, LLC Drug Safety Solutions and Pharmacovigilance Major Business
Table 7. Pharmaceutical Product Development, LLC Drug Safety Solutions and Pharmacovigilance Total Revenue (USD Million) (2017-2018)
Table 8. Pharmaceutical Product Development, LLC SWOT Analysis
Table 9. Pharmaceutical Product Development, LLC Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 10. Pharmaceutical Product Development, LLC Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. AB Cube Corporate Information, Location and Competitors
Table 12. AB Cube Drug Safety Solutions and Pharmacovigilance Major Business
Table 13. AB Cube Drug Safety Solutions and Pharmacovigilance Total Revenue (USD Million) (2018-2019)
Table 14. AB Cube SWOT Analysis
Table 15. AB Cube Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 16. AB Cube Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Worldwide Clinical Trials Corporate Information, Location and Competitors
Table 18. Worldwide Clinical Trials Drug Safety Solutions and Pharmacovigilance Major Business
Table 19. Worldwide Clinical Trials Drug Safety Solutions and Pharmacovigilance Total Revenue (USD Million) (2017-2018)
Table 20. Worldwide Clinical Trials SWOT Analysis
Table 21. Worldwide Clinical Trials Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 22. Worldwide Clinical Trials Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Drug Safety Solutions Limited Corporate Information, Location and Competitors
Table 24. Drug Safety Solutions Limited Drug Safety Solutions and Pharmacovigilance Major Business
Table 25. Drug Safety Solutions Limited Drug Safety Solutions and Pharmacovigilance Total Revenue (USD Million) (2017-2018)
Table 26. Drug Safety Solutions Limited SWOT Analysis
Table 27. Drug Safety Solutions Limited Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 28. Drug Safety Solutions Limited Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Ennov Corporate Information, Location and Competitors
Table 30. Ennov Drug Safety Solutions and Pharmacovigilance Major Business
Table 31. Ennov Drug Safety Solutions and Pharmacovigilance Total Revenue (USD Million) (2017-2018)
Table 32. Ennov SWOT Analysis
Table 33. Ennov Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 34. Ennov Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. C3i Corporate Information, Location and Competitors
Table 36. C3i Drug Safety Solutions and Pharmacovigilance Major Business
Table 37. C3i Drug Safety Solutions and Pharmacovigilance Total Revenue (USD Million) (2017-2018)
Table 38. C3i SWOT Analysis
Table 39. C3i Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 40. C3i Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Accenture Corporate Information, Location and Competitors
Table 42. Accenture Drug Safety Solutions and Pharmacovigilance Major Business
Table 43. Accenture Drug Safety Solutions and Pharmacovigilance Total Revenue (USD Million) (2017-2018)
Table 44. Accenture SWOT Analysis
Table 45. Accenture Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 46. Accenture Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. United Biosource LLC Corporate Information, Location and Competitors
Table 48. United Biosource LLC Drug Safety Solutions and Pharmacovigilance Major Business
Table 49. United Biosource LLC Drug Safety Solutions and Pharmacovigilance Total Revenue (USD Million) (2017-2018)
Table 50. United Biosource LLC SWOT Analysis
Table 51. United Biosource LLC Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 52. United Biosource LLC Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Bioclinica Corporate Information, Location and Competitors
Table 54. Bioclinica Drug Safety Solutions and Pharmacovigilance Major Business
Table 55. Bioclinica Drug Safety Solutions and Pharmacovigilance Total Revenue (USD Million) (2017-2018)
Table 56. Bioclinica SWOT Analysis
Table 57. Bioclinica Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 58. Bioclinica Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Covance Inc. Corporate Information, Location and Competitors
Table 60. Covance Inc. Drug Safety Solutions and Pharmacovigilance Major Business
Table 61. Covance Inc. Drug Safety Solutions and Pharmacovigilance Total Revenue (USD Million) (2017-2018)
Table 62. Covance Inc. SWOT Analysis
Table 63. Covance Inc. Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 64. Covance Inc. Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Cognizant Corporate Information, Location and Competitors
Table 66. Cognizant Drug Safety Solutions and Pharmacovigilance Major Business
Table 67. Cognizant Drug Safety Solutions and Pharmacovigilance Total Revenue (USD Million) (2017-2018)
Table 68. Cognizant SWOT Analysis
Table 69. Cognizant Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 70. Cognizant Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. ICON plc Corporate Information, Location and Competitors
Table 72. ICON plc Drug Safety Solutions and Pharmacovigilance Major Business
Table 73. ICON plc Drug Safety Solutions and Pharmacovigilance Total Revenue (USD Million) (2017-2018)
Table 74. ICON plc SWOT Analysis
Table 75. ICON plc Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 76. ICON plc Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. PRA Health Sciences, Inc. Corporate Information, Location and Competitors
Table 78. PRA Health Sciences, Inc. Drug Safety Solutions and Pharmacovigilance Major Business
Table 79. PRA Health Sciences, Inc. Drug Safety Solutions and Pharmacovigilance Total Revenue (USD Million) (2017-2018)
Table 80. PRA Health Sciences, Inc. SWOT Analysis
Table 81. PRA Health Sciences, Inc. Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 82. PRA Health Sciences, Inc. Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Syneos Health Corporate Information, Location and Competitors
Table 84. Syneos Health Drug Safety Solutions and Pharmacovigilance Major Business
Table 85. Syneos Health Drug Safety Solutions and Pharmacovigilance Total Revenue (USD Million) (2017-2018)
Table 86. Syneos Health SWOT Analysis
Table 87. Syneos Health Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 88. Syneos Health Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Parexel International Corporation Corporate Information, Location and Competitors
Table 90. Parexel International Corporation Drug Safety Solutions and Pharmacovigilance Major Business
Table 91. Parexel International Corporation Drug Safety Solutions and Pharmacovigilance Total Revenue (USD Million) (2017-2018)
Table 92. Parexel International Corporation SWOT Analysis
Table 93. Parexel International Corporation Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 94. Parexel International Corporation Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Genpact Corporate Information, Location and Competitors
Table 96. Genpact Drug Safety Solutions and Pharmacovigilance Major Business
Table 97. Genpact Drug Safety Solutions and Pharmacovigilance Total Revenue (USD Million) (2017-2018)
Table 98. Genpact SWOT Analysis
Table 99. Genpact Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 100. Genpact Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Ergomed Corporate Information, Location and Competitors
Table 102. Ergomed Drug Safety Solutions and Pharmacovigilance Major Business
Table 103. Ergomed Drug Safety Solutions and Pharmacovigilance Total Revenue (USD Million) (2017-2018)
Table 104. Ergomed SWOT Analysis
Table 105. Ergomed Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 106. Ergomed Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Oracle Drug Safety Solutions and Pharmacovigilance Type and Application
Table 108. Oracle Drug Safety Solutions and Pharmacovigilance Major Business
Table 109. Oracle Drug Safety Solutions and Pharmacovigilance Total Revenue (USD Million) (2017-2018)
Table 110. Oracle SWOT Analysis
Table 111. Oracle Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 112. Oracle Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. ArisGlobal Corporate Information, Location and Competitors
Table 114. ArisGlobal Drug Safety Solutions and Pharmacovigilance Major Business
Table 115. ArisGlobal Drug Safety Solutions and Pharmacovigilance Total Revenue (USD Million) (2017-2018)
Table 116. ArisGlobal SWOT Analysis
Table 117. ArisGlobal Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 118. ArisGlobal Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. IQVIA Corporate Information, Location and Competitors
Table 120. IQVIA Drug Safety Solutions and Pharmacovigilance Major Business
Table 121. IQVIA Drug Safety Solutions and Pharmacovigilance Total Revenue (USD Million) (2017-2018)
Table 122. IQVIA SWOT Analysis
Table 123. IQVIA Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 124. IQVIA Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 125. Global Drug Safety Solutions and Pharmacovigilance Revenue (Million USD) by Players (2015-2020)
Table 126. Global Drug Safety Solutions and Pharmacovigilance Revenue Share by Players (2015-2020)
Table 127. Global Drug Safety Solutions and Pharmacovigilance Revenue (Million USD) by Regions (2015-2020)
Table 128. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Regions (2015-2020)
Table 129. North America Drug Safety Solutions and Pharmacovigilance Revenue by Countries (2015-2020)
Table 130. North America Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Countries (2015-2020)
Table 131. Europe Drug Safety Solutions and Pharmacovigilance Revenue (Million USD) by Countries (2015-2020)
Table 132. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue (Million USD) by Countries (2015-2020)
Table 133. South America Drug Safety Solutions and Pharmacovigilance Revenue by Countries (2015-2020)
Table 134. South America Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Countries (2015-2020)
Table 135. Middle East and Africa Drug Safety Solutions and Pharmacovigilance Revenue (Million USD) by Countries (2015-2020)
Table 136. Middle East and Africa Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Countries (2015-2020)
Table 137. Global Drug Safety Solutions and Pharmacovigilance Revenue (Million USD) by Type (2015-2020)
Table 138. Global Drug Safety Solutions and Pharmacovigilance Revenue Share by Type (2015-2020)
Table 139. Global Drug Safety Solutions and Pharmacovigilance Revenue Forecast by Type (2021-2025)
Table 140. Global Drug Safety Solutions and Pharmacovigilance Revenue by Application (2015-2020)
Table 141. Global Drug Safety Solutions and Pharmacovigilance Revenue Share by Application (2015-2020)
Table 142. Global Drug Safety Solutions and Pharmacovigilance Revenue Forecast by Application (2021-2025)
Table 143. Global Drug Safety Solutions and Pharmacovigilance Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Drug Safety Solutions and Pharmacovigilance Picture
Figure 2. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Type in 2019
Figure 3. Standard Form Picture
Figure 4. Customized Form Picture
Figure 5. Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Application in 2019
Figure 6. Biotechnology and Pharmaceuticals Picture
Figure 7. Contract Research Organization (CROS) Picture
Figure 8. Hospital Picture
Figure 9. KPO / BPO Picture
Figure 10. Healthcare Institutions Picture
Figure 11. Others Picture
Figure 12. Global Drug Safety Solutions and Pharmacovigilance Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Drug Safety Solutions and Pharmacovigilance Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Drug Safety Solutions and Pharmacovigilance Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Drug Safety Solutions and Pharmacovigilance Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Drug Safety Solutions and Pharmacovigilance Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Drug Safety Solutions and Pharmacovigilance Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Drug Safety Solutions and Pharmacovigilance Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Drug Safety Solutions and Pharmacovigilance Revenue Market Share in 2019
Figure 21. Global Top 10 Players Drug Safety Solutions and Pharmacovigilance Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Drug Safety Solutions and Pharmacovigilance Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Regions (2015-2020)
Figure 25. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Regions in 2018
Figure 26. North America Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 27. Europe Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 29. South America Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 31. North America Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Countries (2015-2020)
Figure 32. North America Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Countries in 2019
Figure 33. USA Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 34. Canada Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 36. Europe Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Countries in 2019
Figure 38. Germany Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 39. UK Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 40. France Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 41. Russia Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 42. Italy Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Countries in 2019
Figure 45. China Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 46. Japan Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 47. Korea Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 48. India Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 50. South America Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Countries (2015-2020)
Figure 51. South America Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Countries in 2019
Figure 52. Brazil Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 57. UAE Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2015-2020)
Figure 60. Global Drug Safety Solutions and Pharmacovigilance Revenue Share by Type (2015-2020)
Figure 61. Global Drug Safety Solutions and Pharmacovigilance Revenue Share by Type in 2019
Figure 62. Global Drug Safety Solutions and Pharmacovigilance Market Share Forecast by Type (2021-2025)
Figure 63. Global Standard Form Revenue Growth Rate (2015-2020)
Figure 64. Global Customized Form Revenue Growth Rate (2015-2020)
Figure 65. Global Drug Safety Solutions and Pharmacovigilance Revenue Share by Application (2015-2020)
Figure 66. Global Drug Safety Solutions and Pharmacovigilance Revenue Share by Application in 2019
Figure 67. Global Drug Safety Solutions and Pharmacovigilance Market Share Forecast by Application (2021-2025)
Figure 68. Global Biotechnology and Pharmaceuticals Revenue Growth Rate (2015-2020)
Figure 69. Global Contract Research Organization (CROS) Revenue Growth Rate (2015-2020)
Figure 70. Global Hospital Revenue Growth Rate (2015-2020)
Figure 71. Global KPO / BPO Revenue Growth Rate (2015-2020)
Figure 72. Global Healthcare Institutions Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Drug Safety Solutions and Pharmacovigilance Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Drug Safety Solutions and Pharmacovigilance Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Drug Safety Solutions and Pharmacovigilance Revenue Market Forecast (2021-2025)
Figure 78. Europe Drug Safety Solutions and Pharmacovigilance Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue Market Forecast (2021-2025)
Figure 80. South America Drug Safety Solutions and Pharmacovigilance Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Drug Safety Solutions and Pharmacovigilance Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
薬物安全性・ファーマコビジランスソリューションの世界市場 2020年 Market Overview The Drug Safety and Pharmacovigilance Solution market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, valu…- ファーマコビジランス（PV）アウトソーシングの世界市場 2020年 Market Overview The global Pharmacovigilance (PV) Outsourcing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pharmacovi…
- 公共安全セキュリティの世界市場 2020年 Market Overview The Public Safety Security market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- コクシジオイデス症薬剤の世界市場 2020年 Market Overview The global Coccidioidomycosis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Coccidioidomycosis Dr…
- 機能安全R&Dの世界市場 2020年 Market Overview The Functional Safety R&D market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…